US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 1.080
  • -0.030-2.70%
Close Jun 7 16:00 ET
  • 1.070
  • -0.010-0.93%
Post 19:07 ET
44.87MMarket Cap-552P/E (TTM)

Carisma Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.18%-22.43M
-1,486.73%-81.18M
5.87%-16.1M
-152.36%-21M
-29.71%-18.55M
-173.79%-25.53M
86.29%-5.12M
-17.1M
-8.32M
-14.3M
Net income from continuing operations
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
-16.78%-21.4M
-33.86%-19.88M
-117.84%-24.64M
-50.12%-61.23M
---16.74M
---18.33M
---14.85M
Operating gains losses
----
-108.13%-156K
-143.64%-240K
--0
--0
-84.92%84K
--1.92M
--550K
--668K
--144K
Depreciation and amortization
140.14%1.69M
49.87%2.84M
2.41%722K
-4.14%695K
191.84%715K
223.39%705K
177.57%1.89M
--705K
--725K
--245K
Other non cash items
-39.84%1.6M
0.34%6.85M
-21.41%1.38M
-32.99%1.43M
-25.99%1.38M
149.58%2.65M
718.59%6.83M
--1.76M
--2.14M
--1.87M
Change In working capital
-77.19%-7.86M
-112.03%-5.44M
161.16%2.09M
-137.55%-2.4M
60.83%-691K
-110.08%-4.44M
2,993.50%45.2M
---3.42M
--6.39M
---1.76M
-Change in prepaid assets
3.14%-1.57M
176.86%1.05M
283.66%562K
529.74%1.69M
45.94%413K
-1.00%-1.62M
-637.94%-1.36M
---306K
--269K
--283K
-Change in payables and accrued expense
-193.40%-4.76M
-118.84%-708K
195.75%2.45M
-135.94%-2.2M
506.75%663K
-559.49%-1.62M
85.90%3.76M
---2.56M
--6.13M
---163K
-Change in other current liabilities
-50.35%-1.31M
-1.48%-4.73M
35.06%-1.15M
-108.94%-1.66M
38.84%-1.05M
-130.85%-868K
-473.06%-4.66M
---1.78M
---794K
---1.71M
-Change in other working capital
30.65%-224K
-102.20%-1.05M
-81.45%228K
-129.50%-231K
-318.60%-720K
-100.71%-323K
--47.46M
--1.23M
--783K
---172K
Cash from discontinued investing activities
Operating cash flow
12.18%-22.43M
-1,486.73%-81.18M
5.87%-16.1M
-152.36%-21M
-29.71%-18.55M
-173.79%-25.53M
86.29%-5.12M
---17.1M
---8.32M
---14.3M
Investing cash flow
Cash flow from continuing investing activities
99.53%-17K
322.38%72.41M
-24.40%10.44M
1,438.02%29.81M
77.79%35.75M
94.40%-3.6M
-1,640.25%-32.56M
13.81M
-2.23M
20.11M
Net PPE purchase and sale
87.41%-17K
75.71%-1.13M
-75.86%-561K
91.79%-189K
76.04%-247K
86.59%-135K
-149.06%-4.66M
---319K
---2.3M
---1.03M
Net investment purchase and sale
--0
363.58%73.54M
-22.14%11M
39,900.00%30M
70.29%36M
94.53%-3.46M
---27.9M
--14.13M
--75K
--21.14M
Cash from discontinued investing activities
Investing cash flow
99.53%-17K
322.38%72.41M
-24.40%10.44M
1,438.02%29.81M
77.79%35.75M
94.40%-3.6M
-1,640.25%-32.56M
--13.81M
---2.23M
--20.11M
Financing cash flow
Cash flow from continuing financing activities
-98.00%1.35M
86.62%62.18M
106.93%101K
-886.89%-2.03M
-21,252.94%-3.63M
93.55%67.74M
108.74%33.32M
-1.46M
-206K
-17K
Net issuance payments of debt
-1,144.34%-1.32M
-103.81%-1.3M
-51.52%-150K
-25.23%-938K
-529.41%-107K
-100.30%-106K
--34.14M
---99K
---749K
---17K
Net common stock issuance
-92.54%2.29M
--31.24M
--597K
--0
--0
--30.64M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--2K
76.42%187K
427.78%95K
-54.55%40K
--52K
--0
--106K
--18K
--88K
----
Net other financing activities
-98.97%383K
3,576.90%32.06M
67.97%-441K
---1.14M
---3.58M
--37.21M
-151.91%-922K
---1.38M
----
----
Cash from discontinued financing activities
Financing cash flow
-98.00%1.35M
86.62%62.18M
106.93%101K
-886.89%-2.03M
-21,252.94%-3.63M
93.55%67.74M
108.74%33.32M
---1.46M
---206K
---17K
Net cash flow
Beginning cash position
220.76%77.61M
-15.26%24.19M
187.33%83.16M
92.41%76.38M
85.25%62.81M
-15.26%24.19M
-44.87%28.55M
--28.94M
--39.7M
--33.9M
Current changes in cash
-154.62%-21.09M
1,325.87%53.41M
-17.01%-5.56M
163.03%6.78M
134.31%13.58M
621.33%38.61M
81.25%-4.36M
---4.75M
---10.76M
--5.79M
End cash Position
-10.02%56.52M
220.76%77.61M
220.76%77.61M
187.33%83.16M
92.41%76.38M
85.25%62.81M
-15.26%24.19M
--24.19M
--28.94M
--39.7M
Free cash flow
12.57%-22.44M
-741.95%-82.31M
4.37%-16.66M
-99.44%-21.19M
-22.60%-18.79M
-176.40%-25.67M
75.06%-9.78M
---17.42M
---10.62M
---15.33M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.18%-22.43M-1,486.73%-81.18M5.87%-16.1M-152.36%-21M-29.71%-18.55M-173.79%-25.53M86.29%-5.12M-17.1M-8.32M-14.3M
Net income from continuing operations 22.99%-18.98M-41.90%-86.88M-25.20%-20.96M-16.78%-21.4M-33.86%-19.88M-117.84%-24.64M-50.12%-61.23M---16.74M---18.33M---14.85M
Operating gains losses -----108.13%-156K-143.64%-240K--0--0-84.92%84K--1.92M--550K--668K--144K
Depreciation and amortization 140.14%1.69M49.87%2.84M2.41%722K-4.14%695K191.84%715K223.39%705K177.57%1.89M--705K--725K--245K
Other non cash items -39.84%1.6M0.34%6.85M-21.41%1.38M-32.99%1.43M-25.99%1.38M149.58%2.65M718.59%6.83M--1.76M--2.14M--1.87M
Change In working capital -77.19%-7.86M-112.03%-5.44M161.16%2.09M-137.55%-2.4M60.83%-691K-110.08%-4.44M2,993.50%45.2M---3.42M--6.39M---1.76M
-Change in prepaid assets 3.14%-1.57M176.86%1.05M283.66%562K529.74%1.69M45.94%413K-1.00%-1.62M-637.94%-1.36M---306K--269K--283K
-Change in payables and accrued expense -193.40%-4.76M-118.84%-708K195.75%2.45M-135.94%-2.2M506.75%663K-559.49%-1.62M85.90%3.76M---2.56M--6.13M---163K
-Change in other current liabilities -50.35%-1.31M-1.48%-4.73M35.06%-1.15M-108.94%-1.66M38.84%-1.05M-130.85%-868K-473.06%-4.66M---1.78M---794K---1.71M
-Change in other working capital 30.65%-224K-102.20%-1.05M-81.45%228K-129.50%-231K-318.60%-720K-100.71%-323K--47.46M--1.23M--783K---172K
Cash from discontinued investing activities
Operating cash flow 12.18%-22.43M-1,486.73%-81.18M5.87%-16.1M-152.36%-21M-29.71%-18.55M-173.79%-25.53M86.29%-5.12M---17.1M---8.32M---14.3M
Investing cash flow
Cash flow from continuing investing activities 99.53%-17K322.38%72.41M-24.40%10.44M1,438.02%29.81M77.79%35.75M94.40%-3.6M-1,640.25%-32.56M13.81M-2.23M20.11M
Net PPE purchase and sale 87.41%-17K75.71%-1.13M-75.86%-561K91.79%-189K76.04%-247K86.59%-135K-149.06%-4.66M---319K---2.3M---1.03M
Net investment purchase and sale --0363.58%73.54M-22.14%11M39,900.00%30M70.29%36M94.53%-3.46M---27.9M--14.13M--75K--21.14M
Cash from discontinued investing activities
Investing cash flow 99.53%-17K322.38%72.41M-24.40%10.44M1,438.02%29.81M77.79%35.75M94.40%-3.6M-1,640.25%-32.56M--13.81M---2.23M--20.11M
Financing cash flow
Cash flow from continuing financing activities -98.00%1.35M86.62%62.18M106.93%101K-886.89%-2.03M-21,252.94%-3.63M93.55%67.74M108.74%33.32M-1.46M-206K-17K
Net issuance payments of debt -1,144.34%-1.32M-103.81%-1.3M-51.52%-150K-25.23%-938K-529.41%-107K-100.30%-106K--34.14M---99K---749K---17K
Net common stock issuance -92.54%2.29M--31.24M--597K--0--0--30.64M--0--0--0--0
Proceeds from stock option exercised by employees --2K76.42%187K427.78%95K-54.55%40K--52K--0--106K--18K--88K----
Net other financing activities -98.97%383K3,576.90%32.06M67.97%-441K---1.14M---3.58M--37.21M-151.91%-922K---1.38M--------
Cash from discontinued financing activities
Financing cash flow -98.00%1.35M86.62%62.18M106.93%101K-886.89%-2.03M-21,252.94%-3.63M93.55%67.74M108.74%33.32M---1.46M---206K---17K
Net cash flow
Beginning cash position 220.76%77.61M-15.26%24.19M187.33%83.16M92.41%76.38M85.25%62.81M-15.26%24.19M-44.87%28.55M--28.94M--39.7M--33.9M
Current changes in cash -154.62%-21.09M1,325.87%53.41M-17.01%-5.56M163.03%6.78M134.31%13.58M621.33%38.61M81.25%-4.36M---4.75M---10.76M--5.79M
End cash Position -10.02%56.52M220.76%77.61M220.76%77.61M187.33%83.16M92.41%76.38M85.25%62.81M-15.26%24.19M--24.19M--28.94M--39.7M
Free cash flow 12.57%-22.44M-741.95%-82.31M4.37%-16.66M-99.44%-21.19M-22.60%-18.79M-176.40%-25.67M75.06%-9.78M---17.42M---10.62M---15.33M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg